| 2023 |
How is nicotine vaping product (e-cigarette) use monitored in primary care electronic health records in the United Kingdom? An exploratory analysis of Clinical Practice Research Datalink (CPRD)
10.1186/s12889-023-17200-7
Authors: B. Tildy, A. McNeill, J. Robins, A. Dregan, S. Richardson, L. Brose |
| 2009 |
How effective are dose-adjusted warfarin and aspirin for the prevention of stroke in patients with chronic atrial fibrillation? An analysis of the UK General Practice Research Database
Authors: S. Rietbrock, J. Plumb, A. Gallagher, T. van Staa |
| 2000 |
How do symptoms indicative of BPH progress in real life practice? The UK experience
10.1159/000052401
Authors: G. Clifford, J. Logie, R. Farmer |
| 2018 |
How Do Biological Characteristics of Primary Intracranial Tumors Affect Their Clinical Presentation in Children and Young Adults?
10.1177/0883073818767562
Authors: T. Chu, A. Shah, D. Walker, M. Coleman |
| 2024 |
How common are side effects of treatment to prevent gout flares when starting allopurinol?
10.1136/bmj.q514
Authors: H. Saul, B. Deeney, L. Swaithes, E. Roddy |
| 2019 |
How Clinical Practice Research Datalink data are used to support pharmacovigilance
10.1177/2042098619854010
Authors: R. Ghosh, E. Crellin, S. Beatty, K. Donegan, P. Myles, R. Williams |
| 2008 |
How accurate are diagnoses for rheumatoid arthritis and juvenile idiopathic arthritis in the general practice research database?
10.1002/art.24015
Authors: S. Thomas, C. Edwards, L. Smeeth, C. Cooper, A. Hall |
| 2010 |
Hospitalization risk in a type 2 diabetes cohort
Authors: E. Ng, K. McGrail, J. Johnson |
| 2008 |
Hormone therapy and coronary heart disease in young women
10.1097/gme.0b013e3180413e45
Authors: M. Weiner, K. Barnhart, D. Xie, R. Tannen |
| 2006 |
Hormone therapy and cerebrovascular events: a population-based nested case-control study
10.1097/01.gme.0000233494.28335.71
Authors: A. Arana, C. Varas, A. Gonzalez-Perez, L. Gutierrez, L. Bjerrum, L. Rodriguez |
| 1999 |
Hormone replacement therapy: patterns of use studied through British general practice computerized records
Authors: M. Lawrence, L. Jones, T. Lancaster, E. Daly, E. Banks |
| 1995 |
Hormone replacement therapy: characteristics of users and non-users in a British general practice cohort identified through computerised prescribing records
Authors: T. Lancaster, G. Surman, M. Lawrence, D. Mant, M. Vessey, M. Thorogood, P. Yudkin, E. Daly |
| 2008 |
Hormone replacement therapy use and the risk of stroke
10.1016/j.maturitas.2008.09.020
Authors: C. Renoux, S. Dell'Aniello, E. Garbe, S. Suissa |
| 2012 |
Hormone replacement therapy is associated with gastro-oesophageal reflux disease: a retrospective cohort study
10.1186/1471-230x-12-56
Authors: H. Close, J. Mason, D. Wilson, A. Hungin |
| 2010 |
Hormone replacement therapy and the risk of venous thromboembolism: a population-based study
10.1111/j.1538-7836.2010.03839.x
Authors: C. Renoux, S. Dell'Aniello, S. Suissa |
| 1997 |
Hormone replacement therapy and risk of venous thromboembolism: population based case-control study
Authors: Perez Gutthann, L. Rodriguez, J. Castellsague, Duque Oliart |
| 2002 |
Hormone replacement therapy and prevention of pressure ulcers and venous leg ulcers
10.1016/s0140-6736(02)07806-6
Authors: D. Margolis, J. Knauss, W. Bilker |
| 2015 |
Hormone replacement therapy and mid-term implant survival following knee or hip arthroplasty for osteoarthritis: a population-based cohort study
10.1136/annrheumdis-2013-204043
Authors: D. Prieto-Alhambra, M. Javaid, A. Judge, J. Maskell, C. Cooper, N. Arden |
| 2000 |
Hormone replacement therapy and incidence of acute myocardial infarction. A population-based nested case-control study
Authors: C. Varas-Lorenzo, L. Garcia-Rodriguez, S. Perez-Gutthann, A. Duque-Oliart |
| 2006 |
Hormone replacement therapy and cataract: a population-based case-control study
10.1038/sj.eye.6701877
Authors: F. Aina, L. Smeeth, R. Hubbard, L. Hurt, A. Fletcher |
| 2006 |
Hormone replacement therapy and acute myocardial infarction: a large observational study exploring the influence of age
10.1093/ije/dyi285
Authors: J. Kim, S. Evans, L. Smeeth, S. Pocock |
| 2000 |
HMG-CoA reductase inhibitors and the risk of fractures
Authors: C. Meier, R. Schlienger, M. Kraenzlin, B. Schlegel, H. Jick |
| 2015 |
History of cardiovascular events and cardiovascular risk factors among patients initiating strontium ranelate for treatment of osteoporosis
10.2147/ijwh.s88627
Authors: J. Yu, J. Tang, Z. Li, S. Sajjan, C. O\textquoterightRegan, A. Modi, V. Sazonov |
| 2019 |
History of Benzodiazepine Prescriptions and Risk of Dementia: Possible Bias Due to Prevalent Users and Covariate Measurement Timing in a Nested Case-Control Study
10.1093/aje/kwz073
Authors: K. Richardson, K. Mattishent, Y. Loke, N. Steel, C. Fox, C. Grossi, K. Bennett, I. Maidment, M. Boustani, F. Matthews, P. Myint, N. Campbell, C. Brayne, L. Robinson, G. Savva |
| 2016 |
Hip/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): a methodological approach to assess consistencies across databases from the PROTECT-EU project
10.1002/pds.3816
Authors: G. Requena, C. Huerta, H. Gardarsdottir, J. Logie, R. Gonzalez-Gonzalez, V. Abbing-Karahagopian, M. Miret, C. Schneider, P. Souverein, D. Webb, A. Afonso, N. Boudiaf, E. Martin, B. Oliva, A. Alvarez, M. de Groot, A. Bate, S. Johansson, R. Schlienger, R. Reynolds, O. Klungel, F. de Abajo |
| 2004 |
Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort study
Authors: T. Card, J. West, R. Hubbard, R. Logan |
| 2010 |
Hip fracture risk in patients with a diagnosis of pernicious anemia
10.1053/j.gastro.2009.12.007
Authors: N. Merriman, M. Putt, D. Metz, Y. Yang |
| 2022 |
Hip Fracture Risk After Treatment with Tramadol or Codeine: An Observational Study
10.1007/s40264-022-01198-9
Authors: E. Voss, S. Ali, A. Singh, P. Rijnbeek, M. Schuemie, D. Fife |
| 2023 |
Higher rates of non-skeletal complications and greater healthcare needs in achondroplasia compared to the general UK population: a matched cohort study using the CPRD database
10.1186/s13023-023-02811-5
Authors: J. Pimenta, M. Irving, M. Cheung, L. Mazzeo, S. Landis, S. Mukherjee |
| 2020 |
Higher prevalence of non-skeletal comorbidity related to X-linked hypophosphataemia: a UK parallel cohort study using CPRD
10.1093/rheumatology/keaa859
Authors: S. Hawley, N. Shaw, A. Delmestri, D. Prieto-Alhambra, C. Cooper, R. Pinedo-Villanueva, M. Javaid |
| 2012 |
Higher incidence of common diagnoses in patients with low back pain in primary care
10.1111/j.1533-2500.2011.00466.x
Authors: S. Bartholomeeusen, J. Van Zundert, C. Truyers, F. Buntinx, D. Paulus |
| 2014 |
High-potency statin and ezetimibe use and mortality in survivors of an acute myocardial infarction: a population-based study
10.1136/heartjnl-2013-304678
Authors: M. Pauriah, D. Elder, S. Ogston, A . Y. Noman, A. Majeed, J. Wyatt, A. Choy, T. MacDonald, A. Struthers, C. Lang |
| 2009 |
High-dose inhaled corticosteroids versus add-on long-acting beta-agonists in asthma: an observational study
10.1016/j.jaci.2008.09.035
Authors: M. Thomas, J. von Ziegenweidt, A. Lee, D. Price |
| 2016 |
High risk of drug-induced microscopic colitis with concomitant use of NSAIDs and proton pump inhibitors
10.1111/apt.13583
Authors: B. Verhaegh, F. de Vries, A. Masclee, A. Keshavarzian, A. de Boer, P. Souverein, M. Pierik, D. Jonkers |
| 2006 |
High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database
Authors: S. Soedamah-Muthu, J. Fuller, H. Mulnier, V. Raleigh, R. Lawrenson, H. Colhoun |
| 2016 |
High Dose Atorvastatin Associated with Increased Risk of Significant Hepatotoxicity in Comparison to Simvastatin in UK GPRD Cohort
10.1371/journal.pone.0151587
Authors: A. Clarke, P. Johnson, G. Hall, I. Ford, P. Mills |
| 2017 |
Herpes zoster risk after 21 specific cancers: population-based case-control study
10.1038/bjc.2017.124
Authors: E. Hansson, H. Forbes, S. Langan, L. Smeeth, K. Bhaskaran |
| 2019 |
Herpes zoster related healthcare burden and costs in immunocompromised (IC) and IC-free populations in England: an observational retrospective database analysis
10.1136/bmjopen-2018-023502
Authors: D. Curran, M. Hunjan, El Ghachi, Y. El-Hahi, V. Bianco, G. Ferreira |
| 2019 |
Hepatitis B virus infection and the risk of liver disease progression in type 2 diabetic patients with potential nonalcoholic fatty liver disease: a retrospective, observational, cohort study in the United Kingdom Clinical Practice Research Datalink
10.1097/meg.0000000000001537
Authors: G. Ferreira, A. Stuurman, Y. Horsmans, T. Cattaert, T. Verstraeten, Y. Feng, D. Rosillon, A. Guignard |
| 2018 |
Hepatitis B virus infection and diabetes mellitus: An adverse relationship A letter in response to Incidence and prevalence of hepatitis B in patients with diabetes mellitus in the UK: A population-based cohort study using the UK Clinical Practice Researc
10.1111/jvh.12949
Authors: R. Kumar |
| 2018 |
Hemoglobin mRNA Changes in the Frontal Cortex of Patients with Neurodegenerative Diseases
10.3389/fnins.2018.00008
Authors: S. Vanni, M. Zattoni, F. Moda, G. Giaccone, F. Tagliavini, S. Haik, J. Deslys, G. Zanusso, J. Ironside, M. Carmona, I. Ferrer, G. Kovacs, G. Legname |
| 2010 |
Heart failure, myocardial infarction, lung cancer and death in COPD patients: a UK primary care study
10.1016/j.rmed.2010.04.018
Authors: L. Rodriguez, M. Wallander, E. Martin-Merino, S. Johansson |
| 2021 |
Healthcare, Medication Utilization and Outcomes of Patients with COPD by GOLD Classification in England
10.2147/copd.s318969
Authors: L. Sansbury, K. Rothnie, C. Bains, C. Compton, G. Anley, A. Ismaila |
| 2020 |
Healthcare utilization and associated costs following initiation of perampanel in patients with epilepsy
10.1016/j.yebeh.2020.107137
Authors: C. Morgan, S. Varga, W. Tsong, S. Jenkins-Jones, S. Holden |
| 2012 |
Healthcare utilization among patients with depression before and after initiating duloxetine in the United Kingdom
10.3111/13696998.2012.672941
Authors: N. Shi, Z. Cao, E. Durden, A. Schacht, A. Torres, M. Happich |
| 2018 |
Healthcare Utilisation, Morbidities and Alcohol Use Monitoring Prior to Alcoholic Psychosis Diagnosis
10.1093/alcalc/agy085
Authors: H. Otete, M. Fleming, J. West, E. Orton |
| 2023 |
Healthcare utilisation and mortality in people with osteoarthritis in the UK: findings from a national primary care database
10.3399/bjgp.2022.0419
Authors: S. Swain, C. Coupland, A. Sarmanova, C. Kuo, C. Mallen, M. Doherty, W. Zhang |
| 2020 |
Healthcare use by people who use illicit opioids (HUPIO): development of a cohort based on electronic primary care records in England
10.12688/wellcomeopenres.16431.1
Authors: D. Lewer, P. Padmanathan, Qummer Arfeen, S. Denaxas, H. Forbes, A. Gonzalez-Izquierdo, M. Hickman |
| 2020 |
Healthcare trajectories and costs in the last year of life: a retrospective primary care and hospital analysis
10.1136/bmjspcare-2020-002630
Authors: X. Luta, K. Diernberger, J. Bowden, J. Droney, D. Howdon, K. Schmidlin, V. Rodwin, P. Hall, J. Marti |
| 2019 |
Healthcare resource utilization by patients with treatment-refractory myasthenia gravis in England
10.1080/13696998.2019.1592180
Authors: L. Harris, S. Graham, S. MacLachlan, A. Exuzides, S. Jacob |
